671 results on '"Kitchener, Henry"'
Search Results
102. Cervical intraepithelial neoplasia outcomes after large loop excision with clear margins
103. Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study.
104. Preferences for interventions designed to increase cervical screening uptake in non‐attending young women: How findings from a discrete choice experiment compare with observed behaviours in a trial.
105. Pre-Surgical Metformin in Uterine Malignancy (Premium): A Multi-Centre, Randomised Double-Blind, Placebo-Controlled Phase 3 Trial
106. Treatment Of Dysfunctional Uterine Bleeding [with Reply]
107. Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative
108. The Cervix Cancer Research Network: A Global Outreach Effort on Behalf of the Gynecologic Cancer InterGroup
109. The second to fourth digit ratio (2D:4D) in women with and without human papillomavirus and cervical dysplasia
110. To promote maintenance or treatment, is that the question?
111. Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC)
112. Cervical cancer: A global health crisis
113. The Impact of an International Network (Gynecologic Cancer InterGroup) for Clinical Research on Global Capacity for Gynecologic Cancer Clinical Trials
114. Ovary and Fallopian Tube
115. A systems biology approach to understanding the function of 5T4 oncofetal glycoprotein in ovarian cancer and the preclinical effectiveness of a 5T4 antibody drug conjugate
116. Urocortin suppresses endometrial cancer cell migration via CRFR2 and its system components are differentially modulated by estrogen
117. Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale
118. Efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomised, double-blind PATRICIA trial
119. Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04- adjuvanted vaccine against cervical infection and precancer in young women : final event-driven analysis of the randomized, double- blind PATRICIA trial
120. The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk.
121. Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries
122. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC)
123. Premalignant disease in the genital tract in pregnancy
124. Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer
125. Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future
126. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer
127. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer
128. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer
129. Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial
130. HPV testing alone is not as safe as cytology and selective HPV testing
131. The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia
132. Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
133. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia
134. Adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer: Toxicity and quality-of-life results of the randomized PORTEC-3 trial.
135. Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies
136. Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial
137. A study of cellular counting to determine minimum thresholds for adequacy for liquid-based cervical cytology using a survey and counting protocol
138. The Cervix Cancer Research Network: Increasing Access to Cancer Clinical Trials in Low- and Middle-Income Countries
139. A presurgical window-of-opportunity study of metformin in obesity-driven endometrial cancer
140. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis
141. Interventions to improve cervical cancer screening uptake amongst young women : A systematic review
142. Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study
143. Gynaecological oncology
144. Cancer of the Uterine Corpus
145. Cancer of the Uterine Corpus
146. Efficacy of HPV-Based Screening for Prevention of Invasive Cervical Cancer
147. Measurement of Neutralizing Serum Antibodies of Patients Vaccinated with Human Papillomavirus L1 or L2-Based Immunogens Using Furin-Cleaved HPV Pseudovirions
148. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
149. HPV-based screening for prevention of invasive cervical cancer – Authors' reply
150. Interventions to improve cervical cancer screening uptake amongst young women: A systematic review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.